These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 12952841

  • 21. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).
    Athanasopoulos T, Graham IR, Foster H, Dickson G.
    Gene Ther; 2004 Oct; 11 Suppl 1():S109-21. PubMed ID: 15454965
    [Abstract] [Full Text] [Related]

  • 22. Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector.
    Dudley RW, Lu Y, Gilbert R, Matecki S, Nalbantoglu J, Petrof BJ, Karpati G.
    Hum Gene Ther; 2004 Feb; 15(2):145-56. PubMed ID: 14975187
    [Abstract] [Full Text] [Related]

  • 23. Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice.
    Fabb SA, Wells DJ, Serpente P, Dickson G.
    Hum Mol Genet; 2002 Apr 01; 11(7):733-41. PubMed ID: 11929846
    [Abstract] [Full Text] [Related]

  • 24. Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy.
    Athanasopoulos T, Foster H, Foster K, Dickson G.
    Methods Mol Biol; 2011 Apr 01; 709():21-37. PubMed ID: 21194019
    [Abstract] [Full Text] [Related]

  • 25. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model.
    Wang B, Li J, Xiao X.
    Proc Natl Acad Sci U S A; 2000 Dec 05; 97(25):13714-9. PubMed ID: 11095710
    [Abstract] [Full Text] [Related]

  • 26. Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers.
    Jearawiriyapaisarn N, Moulton HM, Sazani P, Kole R, Willis MS.
    Cardiovasc Res; 2010 Feb 01; 85(3):444-53. PubMed ID: 19815563
    [Abstract] [Full Text] [Related]

  • 27. Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice.
    Zhou Y, Zhang C, Xiao W, Herzog RW, Han R.
    Nat Commun; 2024 Jul 21; 15(1):6141. PubMed ID: 39034316
    [Abstract] [Full Text] [Related]

  • 28. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice.
    Watchko J, O'Day T, Wang B, Zhou L, Tang Y, Li J, Xiao X.
    Hum Gene Ther; 2002 Aug 10; 13(12):1451-60. PubMed ID: 12215266
    [Abstract] [Full Text] [Related]

  • 29. Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy.
    Wasala NB, Yue Y, Vance J, Duan D.
    J Mol Cell Cardiol; 2017 Jan 10; 102():45-52. PubMed ID: 27908661
    [Abstract] [Full Text] [Related]

  • 30. [Gene therapy for muscular dystrophy].
    Takeda S.
    No To Hattatsu; 2004 Mar 10; 36(2):117-23. PubMed ID: 15031985
    [Abstract] [Full Text] [Related]

  • 31. Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy.
    Hart CC, Lee YI, Xie J, Gao G, Lin BL, Hammers DW, Sweeney HL.
    JCI Insight; 2024 May 07; 9(11):. PubMed ID: 38713520
    [Abstract] [Full Text] [Related]

  • 32. rAAV6-microdystrophin rescues aberrant Golgi complex organization in mdx skeletal muscles.
    Percival JM, Gregorevic P, Odom GL, Banks GB, Chamberlain JS, Froehner SC.
    Traffic; 2007 Oct 07; 8(10):1424-39. PubMed ID: 17714427
    [Abstract] [Full Text] [Related]

  • 33. Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles.
    Peccate C, Mollard A, Le Hir M, Julien L, McClorey G, Jarmin S, Le Heron A, Dickson G, Benkhelifa-Ziyyat S, Piétri-Rouxel F, Wood MJ, Voit T, Lorain S.
    Hum Mol Genet; 2016 Aug 15; 25(16):3555-3563. PubMed ID: 27378686
    [Abstract] [Full Text] [Related]

  • 34. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
    Xiong F, Xiao S, Peng F, Zheng H, Yu M, Ruan Y, Li W, Shang Y, Zhao C, Zhou W, Chen H, Chamberlain JS, Fang L, Zhang C.
    Hum Gene Ther; 2007 Jun 15; 18(6):490-501. PubMed ID: 17550336
    [Abstract] [Full Text] [Related]

  • 35. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
    Wasala NB, Bostick B, Yue Y, Duan D.
    Hum Mol Genet; 2013 Jul 01; 22(13):2634-41. PubMed ID: 23459935
    [Abstract] [Full Text] [Related]

  • 36. Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin Type IIB receptor in mdx mice.
    Hoogaars WM, Mouisel E, Pasternack A, Hulmi JJ, Relizani K, Schuelke M, Schirwis E, Garcia L, Ritvos O, Ferry A, 't Hoen PA, Amthor H.
    Hum Gene Ther; 2012 Dec 01; 23(12):1269-79. PubMed ID: 22894762
    [Abstract] [Full Text] [Related]

  • 37. Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.
    Wasala NB, Yue Y, Lostal W, Wasala LP, Niranjan N, Hajjar RJ, Babu GJ, Duan D.
    Mol Ther; 2020 Mar 04; 28(3):845-854. PubMed ID: 31981493
    [Abstract] [Full Text] [Related]

  • 38. Live-imaging of revertant and therapeutically restored dystrophin in the DmdEGFP-mdx mouse model for Duchenne muscular dystrophy.
    Petkova MV, Stantzou A, Morin A, Petrova O, Morales-Gonzalez S, Seifert F, Bellec-Dyevre J, Manoliu T, Goyenvalle A, Garcia L, Richard I, Laplace-Builhé C, Schuelke M, Amthor H.
    Neuropathol Appl Neurobiol; 2020 Oct 04; 46(6):602-614. PubMed ID: 32573804
    [Abstract] [Full Text] [Related]

  • 39. Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.
    Betts CA, Saleh AF, Carr CA, Hammond SM, Coenen-Stass AM, Godfrey C, McClorey G, Varela MA, Roberts TC, Clarke K, Gait MJ, Wood MJ.
    Sci Rep; 2015 Mar 11; 5():8986. PubMed ID: 25758104
    [Abstract] [Full Text] [Related]

  • 40. [Construction of recombinant adenovirus including microdystrophin and expression in the mesenchymal cells of mdx mice].
    Xiong F, Zhang C, Xiao SB, Li MS, Wang SH, Yu MJ, Shang YC.
    Sheng Wu Gong Cheng Xue Bao; 2007 Jan 11; 23(1):27-32. PubMed ID: 17366884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.